Annual lung cancer screening with low-dose computed tomography (LDCT) is recommended for adults ages 50 to 80 who have a 20 pack-year smoking history and currently smoke, or have quit within the past 15 years.
Inova’s Lung Cancer Screening program is designed to detect cancer in its earliest, most treatable stage. LDCT technology generates cross-sectional images of the body, using less ionizing radiation than a conventional CT scan.
Should cancer be detected, a multidisciplinary team of board certified interventional pulmonologists, thoracic surgeons and thoracic medical and radiation oncologists work hand-in-hand to coordinate and manage your care. Inova patients have access to advanced medical technology including robotic-assisted bronchoscopy and endobronchial ultrasound (EBUS), cutting-edge clinical trials, and world-class surgeons who regularly perform complex thoracic surgeries. We offer comprehensive, minimally invasive diagnostic and treatment options for lung cancer patients.
Lung Cancer Screening appointments can be made at any of these locations. To schedule an appointment or learn more about our program, please call 571-472-3500 or complete our online form.
Who should consider yearly screenings for America’s most deadly cancer?
Diagnostic screenings for those considered at-risk for lung cancer can save lives, but very few people get them done. Lung cancer is the deadliest cancer in the U.S., killing more people each year than breast, colon and prostate cancers combined.
The Centers for Medicaid and Medicaid Services (CMS) recently expanded its coverage of LDCT to improve health outcomes for people with lung cancer.